Cargando…

Machine learning in the development of targeting microRNAs in human disease

A microRNA is a small, single-stranded, non-coding ribonucleic acid that plays a crucial role in RNA silencing and can regulate gene expression. With the in-depth study of miRNA in development and disease, miRNA has become an attractive target for novel therapeutic strategies. Exploring miRNA target...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yuxun, Peng, Li, Shan, Wenyu, Sun, Mengyue, Luo, Lingyun, Liang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845262/
https://www.ncbi.nlm.nih.gov/pubmed/36685965
http://dx.doi.org/10.3389/fgene.2022.1088189
_version_ 1784870858989240320
author Luo, Yuxun
Peng, Li
Shan, Wenyu
Sun, Mengyue
Luo, Lingyun
Liang, Wei
author_facet Luo, Yuxun
Peng, Li
Shan, Wenyu
Sun, Mengyue
Luo, Lingyun
Liang, Wei
author_sort Luo, Yuxun
collection PubMed
description A microRNA is a small, single-stranded, non-coding ribonucleic acid that plays a crucial role in RNA silencing and can regulate gene expression. With the in-depth study of miRNA in development and disease, miRNA has become an attractive target for novel therapeutic strategies. Exploring miRNA targeting therapy only through experiments is expensive and laborious, so it is essential to develop novel and efficient computational methods to narrow down the search. Recent advances in machine learning applied in biomedical informatics provide opportunities to explore miRNA-targeting drugs, thus promoting miRNA therapeutics. This review provides an overview of recent advancements in miRNA targeting therapeutic using machine learning. First, we mainly describe the basics of predicting miRNA targeting drugs, including pharmacogenomic data resources and data preprocessing. Then we present primary machine learning algorithms and elaborate their application in discovering relationships among miRNAs, drugs, and diseases. Along with the progress of miRNA targeting therapeutics, we finally analyze and discuss the current challenges and opportunities that machine learning confronts.
format Online
Article
Text
id pubmed-9845262
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98452622023-01-19 Machine learning in the development of targeting microRNAs in human disease Luo, Yuxun Peng, Li Shan, Wenyu Sun, Mengyue Luo, Lingyun Liang, Wei Front Genet Genetics A microRNA is a small, single-stranded, non-coding ribonucleic acid that plays a crucial role in RNA silencing and can regulate gene expression. With the in-depth study of miRNA in development and disease, miRNA has become an attractive target for novel therapeutic strategies. Exploring miRNA targeting therapy only through experiments is expensive and laborious, so it is essential to develop novel and efficient computational methods to narrow down the search. Recent advances in machine learning applied in biomedical informatics provide opportunities to explore miRNA-targeting drugs, thus promoting miRNA therapeutics. This review provides an overview of recent advancements in miRNA targeting therapeutic using machine learning. First, we mainly describe the basics of predicting miRNA targeting drugs, including pharmacogenomic data resources and data preprocessing. Then we present primary machine learning algorithms and elaborate their application in discovering relationships among miRNAs, drugs, and diseases. Along with the progress of miRNA targeting therapeutics, we finally analyze and discuss the current challenges and opportunities that machine learning confronts. Frontiers Media S.A. 2023-01-04 /pmc/articles/PMC9845262/ /pubmed/36685965 http://dx.doi.org/10.3389/fgene.2022.1088189 Text en Copyright © 2023 Luo, Peng, Shan, Sun, Luo and Liang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Luo, Yuxun
Peng, Li
Shan, Wenyu
Sun, Mengyue
Luo, Lingyun
Liang, Wei
Machine learning in the development of targeting microRNAs in human disease
title Machine learning in the development of targeting microRNAs in human disease
title_full Machine learning in the development of targeting microRNAs in human disease
title_fullStr Machine learning in the development of targeting microRNAs in human disease
title_full_unstemmed Machine learning in the development of targeting microRNAs in human disease
title_short Machine learning in the development of targeting microRNAs in human disease
title_sort machine learning in the development of targeting micrornas in human disease
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845262/
https://www.ncbi.nlm.nih.gov/pubmed/36685965
http://dx.doi.org/10.3389/fgene.2022.1088189
work_keys_str_mv AT luoyuxun machinelearninginthedevelopmentoftargetingmicrornasinhumandisease
AT pengli machinelearninginthedevelopmentoftargetingmicrornasinhumandisease
AT shanwenyu machinelearninginthedevelopmentoftargetingmicrornasinhumandisease
AT sunmengyue machinelearninginthedevelopmentoftargetingmicrornasinhumandisease
AT luolingyun machinelearninginthedevelopmentoftargetingmicrornasinhumandisease
AT liangwei machinelearninginthedevelopmentoftargetingmicrornasinhumandisease